Brokerages predict that ICU Medical (NASDAQ:ICUI) will announce $1.81 earnings per share for the current quarter, Zacks Investment Research reports. Two analysts have issued estimates for ICU Medical’s earnings. The highest EPS estimate is $1.85 and the lowest is $1.77. ICU Medical reported earnings of $1.68 per share in the same quarter last year, which indicates a positive year-over-year growth rate of 7.7%. The firm is scheduled to report its next earnings results after the market closes on Wednesday, May 9th.

According to Zacks, analysts expect that ICU Medical will report full-year earnings of $7.00 per share for the current fiscal year, with EPS estimates ranging from $6.90 to $7.16. For the next fiscal year, analysts anticipate that the firm will post earnings of $8.84 per share, with EPS estimates ranging from $8.35 to $9.36. Zacks Investment Research’s earnings per share calculations are an average based on a survey of sell-side analysts that that provide coverage for ICU Medical.

ICU Medical (NASDAQ:ICUI) last issued its earnings results on Thursday, March 1st. The medical instruments supplier reported $2.98 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.04 by $1.94. ICU Medical had a net margin of 5.31% and a return on equity of 8.42%. The business had revenue of $370.12 million during the quarter, compared to analysts’ expectations of $332.91 million. During the same quarter in the prior year, the business posted $1.20 EPS. The company’s revenue for the quarter was up 286.8% on a year-over-year basis.

Several research analysts have recently issued reports on the stock. BidaskClub upgraded shares of ICU Medical from a “buy” rating to a “strong-buy” rating in a report on Saturday. Zacks Investment Research upgraded shares of ICU Medical from a “hold” rating to a “buy” rating and set a $266.00 target price for the company in a report on Tuesday, January 23rd. Two equities research analysts have rated the stock with a hold rating, two have issued a buy rating and one has assigned a strong buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and an average price target of $266.00.

In related news, Director George A. Lopez sold 26,475 shares of the stock in a transaction on Wednesday, April 4th. The shares were sold at an average price of $246.73, for a total transaction of $6,532,176.75. Following the completion of the sale, the director now owns 494,025 shares in the company, valued at approximately $121,890,788.25. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director George A. Lopez sold 7,640 shares of the stock in a transaction on Wednesday, March 21st. The stock was sold at an average price of $253.83, for a total transaction of $1,939,261.20. Following the sale, the director now owns 526,574 shares of the company’s stock, valued at approximately $133,660,278.42. The disclosure for this sale can be found here. In the last quarter, insiders have sold 55,452 shares of company stock valued at $13,775,146. 12.50% of the stock is owned by company insiders.

A number of large investors have recently modified their holdings of ICUI. BlackRock Inc. boosted its stake in ICU Medical by 3.4% during the 4th quarter. BlackRock Inc. now owns 1,879,874 shares of the medical instruments supplier’s stock worth $406,052,000 after purchasing an additional 62,605 shares during the period. Castleark Management LLC lifted its stake in shares of ICU Medical by 3,016.5% in the 4th quarter. Castleark Management LLC now owns 51,110 shares of the medical instruments supplier’s stock worth $11,040,000 after acquiring an additional 49,470 shares during the period. Gotham Asset Management LLC acquired a new stake in shares of ICU Medical in the 4th quarter worth $9,242,000. Raymond James Financial Services Advisors Inc. lifted its stake in shares of ICU Medical by 312.0% in the 4th quarter. Raymond James Financial Services Advisors Inc. now owns 49,448 shares of the medical instruments supplier’s stock worth $10,681,000 after acquiring an additional 37,445 shares during the period. Finally, Barrett Asset Management LLC lifted its stake in shares of ICU Medical by 472.2% in the 4th quarter. Barrett Asset Management LLC now owns 36,480 shares of the medical instruments supplier’s stock worth $7,880,000 after acquiring an additional 30,105 shares during the period. Hedge funds and other institutional investors own 76.90% of the company’s stock.

Shares of ICU Medical stock opened at $256.55 on Friday. ICU Medical has a 12-month low of $152.50 and a 12-month high of $265.27. The firm has a market capitalization of $5,168.07, a PE ratio of 46.48, a P/E/G ratio of 2.57 and a beta of 0.36.

About ICU Medical

ICU Medical, Inc develops, manufactures, and sells medical devices used in vascular therapy, critical care, and oncology applications worldwide. It offers infusion therapy products comprising a tube running from a bottle or plastic bag containing a solution to a catheter inserted in a patient's vein.

Get a free copy of the Zacks research report on ICU Medical (ICUI)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.